Our findings highlight the pro-apoptotic and anti-autophagic roles of HOXA9 in skin tissue, support our previous finding that HOXA9 acts as tumor suppressor in cSCC, and emphasize a newly identified HOXA9- NF-κB axis that may provide novel intervention targets for cSCC therapy. The gene discussed is NFKB1; the disease is skin squamous cell carcinoma.